Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.3415 | 13 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.32523 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.32595 | 13 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.2868 | 13 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.29131 | 14 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.37888 | 13 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.3198 | 12 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.30521 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.30168 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.31123 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.30938 | 13 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.30245 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.31739 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.31643 | 13 |